Randomized Controlled Trials
Research gap analysis derived from 2 medicine papers in our local library.
The gap
Larger, well-designed randomized controlled trials are needed to validate clinical efficacy and establish evidence-based practices for treatments ranging from Sophora flavescens film in postpartum care to efgartigimod in Guillain-Barré syndrome.
Consensus across the literature
The papers collectively leave open the need for rigorous RCTs to confirm findings across various medical interventions.
Research trend
Emerging — attention growing, methods still coalescing.
Supporting evidence — 2 representative gaps
- Effectiveness, safety, and pharmacoeconomic profile of Sophora flavescens film in the treatment of postpartum vaginal dysbiosis: a non-randomized controlled trial (2026) · doi
Large-scale, multicenter, randomized controlled trials are warranted to confirm these findings and to establish definitive evidence for the clinical and economic value of Sophora flavescens film in postpartum care.
Keywords: large scale multicenter randomized controlled trials warranted confirm establish definitive evidence clinical economic value sophora - Correction: Exercise training affects hemodynamics and exercise capacity in cases of heart failure with preserved ejection fraction: a non-randomized controlled trial in individuals aged 65–80 years (2026) · doi
Multi-center randomized controlled trials with larger sample sizes are needed to validate the findings and establish clinical generalizability
Keywords: multi center randomized controlled trials larger sample sizes needed validate establish clinical generalizability
Explore this gap further
Search “Randomized Controlled Trials” across open scholarly engines for the latest related literature.
Working on this gap? Publish with us.
Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.
Free tools for your next paper
Related gaps in Medicine
- Liability and legal frameworks for organizations using AI in clinical decision-making processes require development and clarification.Liability and legal frameworks for organizations using AI in clinical decision-making processes require development and clarification.
- Recent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC. By implementing VFMs to mitigate imaging domain shifts andRecent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC.…
- PURPOSE: The aim of this review was to critically appraise the literature on the use of antibiotics to treat peri-implantitis, with the ultimate goal of supporting evidence-based clinical recommendatiPURPOSE: The aim of this review was to critically appraise the literature on the use of antibiotics to treat peri-implantitis, with the ulti…
- External validation is required before the model can be applied in clinical settings.External validation is required before the model can be applied in clinical settings.